Seventy-jive years have elapsed since the jirst claim that the use of local anaesthetics improved surgical outcome. Despite extensive research, the literature provides contradictory views of the role of regional block in improving outcome. This paper attempts to reconcile these contradictions by examining biological hypotheses underlying the research question and reviewing relevant epidemiological clinical research methodology. The paper concludes with recommendations to prospective investigators for strategies in design, planning and execution of randomised trials to assess the efficacy of regional block in determining outcome after surgery.
There is no simple answer to the question posed by the title. This paper provides a rationale as to why a clear answer has not emerged in the seventyfive years that have elapsed since it was first claimed that local anaesthetics improved surgical outcome. 1 A review of key publications helps explain why the anaesthesia literature is confusing and contradictory on this issue. Some ideas are advanced to show how future studies might provide better evidence for outcome improvement. The paper is in three sections: I. Definition of the research question; 2. Review of the principles of design, execution and analysis of clinical research; and 3. Planning future studies. I. DEFINITION OF THE RESEARCH QUESTION In surgical patients with an otherwise normal or near-normal life expectancy, can the anaesthetist use techniques that improve significantly longterm outcome? Does an anaesthetic regimen that incorporates an intense regional neural block, induced by local anaesthetic drugs, to obtund all the neural, autonomic and metabolic responses to surgical trauma, that otherwise characterise major surgery during the operative and postoperative period, lead to improved outcome after surgery?
This question presupposes an underlying biological hypothesis which has been alluded to by *F.F.A.R.A.C.S., Senior Visiting Anaesthetist.
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The stress of surgery sets in train a series of neural, autonomic and metabolic 'consequences', collectively recognised as the 'metabolic response to trauma',12 Many of these 'consequences' contribute to pathological disturbances'. These, in turn, lead to recognisable 'clinical complications' or morbidity. For example, surgical stress activates the sympathoadrenal system. Sympatho-adrenal activation causes tachycardia, hypertension and increased cardiac output. The extra metabolic demand and after/oad can lead to myocardial ischaemia, ventricular arrhythmias, and possibly myocardial infarction, cardiac arrest and/or major cerebrovascular complications.
The central element of the hypothesis is that complete obtundation of the stress response by local anaesthetic drugs prevents the physiological responses and the cascade of events that leads to clinical complications. Stress responses are activated by surgery and by other stimuli in the postoperative period (such as those caused by patient movement), In order to test this hypothesis adequately, it is essential that major operative and postoperative pain (stress) stimuli be blocked completely.
Anaesthesia and surgery both involve technical invasive procedures which, in themselves, can be associated with serious morbidity and mortality, although the extent and causes of these are controversial. 13 It is important to distinguish morbidity and mortality associated with technical error, or mechanical misadventure, from the general complications related to such factors as preexisting disease, age, obesity and the site, nature, extent and duration of the surgical procedure. The former complications are avoidable in the sense that they result from human error. However, for the purpose of examining what anaesthetists can do to improve long-term surgical outcome, human error causes of anaesthetic and surgical morbidity and mortality are irrelevant. Patients having such complications should be excluded from study and analysis. Furthermore, this source is less than 2.5% of total surgical morbidity and mortality. 14
DESIGN, EXECUTION AND ANALYSIS OF CLINICAL
RESEARCH Clinicians usually employ one or more of three techniques to decide on the best treatment for their patient. 15 The first technique is the method of induction; on the basis of personal retrospective analyses of one's experience or the extension of current concepts of disease, one can logically decide on a treatment that ought to work. The second technique is the method of abdication: on the basis of recommendations from others (colleagues, pharmaceutical representatives, etc), one can accept a treatment of faith. The third is the method of deduction or the hypothetico-deductive approach; an hypothesis is used to generate a formal, randomised control trial (RCT), designed to expose useless or harmful therapy.
The Randomised Control Trial
There is evidence that the hypothetico-deductive approach is more likely to lead to a correct decision. 15 . 2o Accordingly, RCTs have become more common and have demonstrated the efficacy of many treatments and the uselessness of others. 15 Complete evaluation of a treatment by a RCT requires rigorous attention to many details to ensure both validity and applicability. 15,20-22 Sackett and his colleagues listed six questions that a clinician should ask of any published RCT.15 These are: 2.1.1
Was assignment of patients to treatments really randomised? Every patient should have the same known probability (0.5) of receiving one or the other of the treatments being compared.
2.1.2
Were all clinically relevant outcomes reported? Because clinical disagreement is ubiquitous, outcomes must be defined in terms of precise unambiguous, objective criteria; and they must be measured by observers who are 'blind' to whether the patient was in the treatment or the control group. 
2.1.3
Were the study patients recognisably similar to those in your own practice? The clinician reader must be able to predict with confidence clinical outcomes expected in specific patients given recommended therapy.
2.1.4
Were both clinical and statistical significances considered? Clinical significance is a judgment decision about the magnitude of the differences between control and experimental treatments. It refers to the clinical importance attached to the result by the investigator and readers of the report. This can be objectively assessed by identifying a 'substantial improvement in quality of life' or 'substantial change in the way clinicians manage patients as a consequence of their knowledge of the results'. By contrast, statistical significance is a measure of ' the likelihood of the truth of an article's conclusions,' regardless of whether or not they are clinically important.
Consideration of the likelihood of the truth or otherwise of an article's conclusion and the contrast between clinical and statistical significance leads directly to a fundamental issue in the design of a RCT: the prior determination of sample size, which is discussed in more detail in paragraph 2.2.
2.1.5
Is the therapeutic manoeuvre feasible in your practice? There are four considerations here. First, is it described ir.. enough detail that it can be replicated precisely? Second, the manoeuvre must be clinically and biologically sensible. Third, it must be available to both clinicians and patients; and finally two specific biases must be avoided. These are (I) contamination; this occurs when control patients accidentally receive the experimental treatment, and leads to spurious reduction in differences in outcome between experimental and control groups, and (2) co-intervention; or the application of additional management procedures to experimental, but not to control patients: this results in a spurious increase in differences between outcomes of experimental and control groups.
2.1.6
Were all the patients who entered the study accounted for at its conclusion? All patients randomised should be included in the final analysis.
The Determination Of Sample Size
Except for ensuring proper randomisation to provide truly comparable control and experimental groups, prior determination of sample size is the most important procedure in planning a RCT. 15, [20] [21] [22] The crucial question is 'How many patien~s should be studied so that a clinically important therapeutic effect can be detected if it truly existsT Frieman and her colleagues were the first to quantify inadequacy of sample size determination. 2o They surveyed 71 published clinical drug trials with 'negative' results; that is, the authors concluded that the experimental treatment was no better than control. They re-examined the data of each of these trials to determine if a sufficient number of patients had been studied, so that there was greater than 90% probability that a 25% or 50% therapeutic improvement could have been detected. They found that 67 of 71 trials had a greater than 10% chance of missing a true 25% improvement. Fifty of the 71 had a greater than 10% chance of missing a true 50% improvement due to the experimental treatment. Could it be possible that RCTs designed to study the impact of regional block on surgical outcome have been flawed similarly? Detailed consideration of sample size determination is beyond the scope of this review and is given elsewhere. 15 ,20,23,24 However, prospective investigators or clinicians who wish to evaluate published RCTs more critically should have a thorough understanding of the concepts of Type I and Type 11 errors.
The basic aim of a RCT is to estimate the true response for a test treatment and to compare this with an estimate of the true response for a control treatment. Even if the treatments are truly equal, there will be observed differences experimentally, occurring by chance. Various sizes of this difference have various probabilities. There is a particular probability below which we reject the notion (the hypothesis) that the treatments are the same. This is the level of significance and is generally (arbitrarily) set at 0.05. Thus if the probability (P) ~ 0.05, we reject the notion (the null hypothesis, Ho) that the treatments are the same. When we reject Ho and conclude that there is a difference between the treatments, we create a risk that this conclusion is wrong. The wrong decision is termed a type I error; and when we select 0.05 as the cut-off probability for rejecting Ho, we arbitrarily assign the probability of type I error (a) as 0.05.
However, the test procedure has another risk; the risk of concluding that there is no difference when in fact, there is a true difference between treatments. This wrong conclusion is termed a type 11 error; the probability of making this error is designated /3. In contrast to n, which is determined when the investigator sets a level of significance, /3 has an infinite range of possible values.
The probability of type 11 error is based upon the situation where the null hypothesis is false. In this situation, the difference, 6, between experimental and the control treatments has an infinite range of possible values. For each value of 6, there is corresponding value of/3. Thus, we can construct an entire curve of /3 as a function of 6; this curve is designated the receiver operating characteristic (ROC curve) of the particular trial. 20 Figure 1 is taken from Frieman et af.2° as an example of a ROC curve and is based on a RCT they reviewed. 25 In this example, control group sample size (ne) = 64, treatment group (n t ) = 66 and n = 0.05. Endpoint (outcome) is case fatality. In this plot the difference (6) in response rate (mortality rate) for control (Pc) and treatment (Pt) groups is plotted against /3. We enter the graph on the horizontal scale with any value of 6 that interests us and read from the vertical scale /3, the probability of not rejecting Ho when Ho is false.
In Figure 1 , two examples of common clinical interest are shown; 25% and 50% reduction in mortality. These examples show that this RCT would have a 77% likelihood of ruling in favor of 6 = 0, when true 6 = 0.074 (25% mortality reduction) and a 42% likelihood of falsely concluding that 6 = 0, when true 6 = 0.149 (50% mortality reduction).
These values are unacceptably high, a situation that can be prevented by prior planning to determine sample size. 20 ,23,24 These sources provide tables that show minimum sample size per group to satisfy various combinations of a, 13 and 6 for a reasonable range of Pc values, taking into account the random nature of Pc-Pt. The tables commonly consider, 1-13 (termed the power of the trial), since this expresses the probability of avoiding a type 11 error. In the example given above, the authors could have asked, before the study began, what sample size was required for a ~ 0.05 and 13 ~ 0.10, for 6 = 50% reduction in mortality. By referring to the appropriate tables, it would have been possible to determine that a minimum of 202 patients was required for each of the control and experimental groupS. 23 It becomes clear that in planning of a RCT, calculated sample sizes may be beyond practical limits. In this situation, compromise is required to achieve a manageable sample size; by allowing for a larger a or 13 or both, and/or settling for a larger 6. Frieman et at. noted that adequate planning rarely occurred and concluded that many therapies discarded as 'ineffective' after 'negative' RCTs may well have an important therapeutic effect. 20 A similar conclusion might also pertain to many clinical studies that purport to show that regional anaesthesia does not improve surgical outcome.
Sample 'Quality' or 'Structure'
This is a term which I use to describe the nature of samples that might be generated for the purpose of conducting a RCT to determine the impact of regional anaesthesia on surgical outcome. To begin to evaluate this aspect of research design, it is necessary to examine national hospital surgical mortality and morbidity statistics. Data from the United States show that over 97% of surgical deaths are related to factors other than anaesthesia per se. 26 The intensive study of seventeen P.A.S. hospitals· showed a surgical death or morbidity rate for common major surgical procedures in these hospitals, approximately twenty years ago, of 4.8%.27 If we assume, arbitrarily, that ten to eleven per cent of the deaths or morbidity is preventable, in terms of the research question posed here, then five patients per 1,000 among all unselected general surgical hospital inpatients will suffer preventable death or serious morbidity. In a selected group of very high-risk cases, it seems reasonable to assume ·Professional Activity Survey, Commission on Professional and Hospital Activities, 1968 Green Road, Ann Arbor, Michigan 48105.
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Accordingly, the problem in terms of research design and sample size determination may be defined as follows: what sample sizes are required for a prospective study to detect a 50% decrease in death or morbidity (from a rate of5 per 1,000to 2.5 per 1,000) in an unselected hospital group? When the research problem is defined in this way, it is clear that a study of consecutive patients, in the typical general surgical hospital setting, will require enormous sample sizes in order to reduce the risk to an acceptable level of not finding an effect when it truly exists.
The major solution to this problem is to apply a selective filter process to these patients so that only very high-risk patients are entered into a RCT. The difference in sample 'structure' or 'quality' generated in this way is the main reason for the conflicting results and conclusions of two of the more important studies in the recent literature 28 ,29 and has been recognised explicitly. 30 In more general terms, Brown identified some further commonsense approaches to help reduce sample size required. 26 Detailed study of his advice further assists in understanding apparent conflicts in the literature.
Non-randomised Research
The major defect in inductive approaches to clinical decision making is that they fail to eliminate error. 1S ,31 Such studies seek confirmatory evidence for the value of a therapy but fail to conduct experiments to show that treatment is harmful or useless. On the other hand, the RCT provides a rigorous opportunity to demonstrate the worthlessness of a treatment. Sackett has described a detailed catalogue of biases that can distort the results of non-randomised studies and lead to spurious conclusions. 19 It is pOSSIble for a randomised trial to lead to an incorrect conclusion especially when sample size is small. On the other hand, it is also possible to conclude correctly that treatment is helpful or harmful, without the benefit of a RCT. For example, before 1946, all patients with tuberculous meningitis died. After the introduction of streptomycin, many survived. The ability of replicated non-randomised studies to demonstrate this was sufficient evidence of efficacy.1S In.a recent study, 148 consecutive patients were referred for evaluation of risk before major surgery.32 Using pulmonary artery catheters to obtain a complete haemodynamic assessment, patients were separated into four groups according to severity of haemodynamic derangement. Thirty-four patients had the most severe abnormalities; 26 had minor or palliative surgery under local anaesthesia or had medical therapy only, and all survived. Eight patients underwent major surgery as planned and all died. One does not need a RCT to show that the difference between 100% survival and 100% mortality is clinically important. Two further conclusions can be made from these data: first, combined regional and general anaesthesia may not improve outcome in patients who have advanced, uncorrectable cardiopulmonary problems, when their surgeons propose and perform major surgery. They will be likely to die with any anaesthetic regimen. Second, anaesthetists and internists, on the basis of a thorough preoperative workup and their knowledge of proposed surgery, have an important role in advising surgeons, patients and families on possible outcomes of different procedures.
PLANNING FUTURE STUDIES
Properly conducted RCTs provide the only reliable basis for evaluation of comparative efficacy of alternative management strategies. 33 Essential features of a RCT established to evaluate the impact of epidural block on outcome of very high-risk patients undergoing major surgery are: (1) a biologically plausible rationale for the underlying hypothesis, (2) elimination of bias; random allocation eliminates most biases; careful execution prevents contamination and co-intervention, (3) ensuring only very high-risk patients undergoing major surgery are studied; this is essential to achieve a manageable sample size, with acceptable risks of types I and 11 errors, (4) follow-up of all eligible patients and all outcomes for all allocated patients.
Recommendations, General
Successful management of a complex research endeavour requires detailed planning and ongoing communication between the research team and the many clinicians whose patients will be admitted to a RCT. Essential features of such management include the following:
Full delineation of research objectives in writing, all individuals having clearly defined responsibilities, accountabilities and lines of communication.
3.1.2
Quality assurance processes; procedures for monitoring progress towards objectives, and for regular and continuing re-evaluation of objectives and strategy.
3.1.3
Leadership. Someone must be exclusively available to monitor progress of all patients in the trial. Ideally, this is a specifically trained and appointed research nurse, who is crucial to quality and completion of data collection. This requires a detailed data manual, in which all variables are defined in detail. Members of the clinical team must be fully instructed and monitored for clinical data recording. The leader is responsible for surveillance of all patients for early and late morbidity and mortality and for follow-up of all eligible patients.
3.1.4
Pre-defined data handling processes. Statistical consultants should be involved from the time of the initial research plan.
3.1.5
Definition and funding of all manpower and other resource needs.
3.1.6
Identifying a time frame for completion of the study. This includes data collection, storage, summary, analysis and interpretation. 3.1.7
Prior involvement of and extensive discussions with key clinicians whose patients will be admitted to the study. Anaesthetists, surgeons and intensivists who will care for patients must have complete understanding of the rationale, and the requirements for randomisation, evaluation of risk, outcome criteria and bias prevention.
All clinicians whose involvement and cooperation is essential must have: (1) a convincing statement as to the necessity for the trial, (2) certainty that the experimental manoeuvre is clinically sensible, (3) instructions for minimum requirements for documentaton on their part. (Follow-up is the responsibility of the research team, as overburdened clinicians tend to lose interest and may limit quality of the study), and (4) understanding of the outcome for themselves (e.g. increased knowledge, increased prestige, acknowledgement in or involvement with subsequent presentations and publications).
3.1.8
Prior determination of minimum criteria for execution of the trial, with commitment to abandoning it if these cannot be met. Such criteria include minimum rate of patient entry, minimum quality of the experimental manoeuvre, minimum standard of documentation, minimum standards of protocol adherence and criteria for an 'early look' at the results, and for not continuing the RCT if a given proportion of highly significant findings are found.
Recommendations, Specific
In addition to the above general matters pertinent to the successful conduct ofa RCT, there are important issues specific to the question of studying the impact of epidural block on surgical outcome in high-risk patients. These are detailed below:
Admission criteria. It is essential to study only very high-risk patients selected from the general sample of patients that present for operations at major teaching hospitals. The elements of risk in these patients are numerous. They include duration, sites, and extent of surgery, obesity, advanced age, perioperative blood loss, diabetes mellitus, respiratory, cardiac, vascular, renal, hepatic, pancreatic and musculoskeletal disease, malignancy and nutritional and immunological disorders. Most risk factors have a substantial component of mutual interdependence which can vary among cases. 29 ,34 For example, a major problem in assessing obesity quantitatively as a risk factor is its well known association with diseases that are themselves important risk factors, such as cardiac, vascular and liver disease, and diabetes mellitus. 35 Furthermore, risk cannot be quantitated precisely preoperatively because a major component of risk is determined intraoperatively. For example, intraoperative findings and complications can render surgery on the abdominal aorta much more risky because ofthe greater extent and duration of surgery and excessive blood loss. Soper and McPeek reported on the American Society of Anesthesiologists (ASA) Physical Status Risk Classification for over 61,000 consecutive patients anaesthetised at the Massachusetts General Hospital between 1973 and 1976. 36 Overall mortality (2.6%) was in line with national mortality figures. 27 ASA Category 5 patients had a mortality rate of 72.4%, Category 4, 25.9% and Category 3, 4.6%. Category 5 patients are not expected to live more than 24 hours with or without surgery and, on that basis alone, should be excluded from study. The combined mortality of Categories 1 and 2 was 0.3%. Accordingly, it appears that optimum criteria for eligibility for admission are: (1) Attending anaesthetists classify patient risk as ASA category 3 or 4, (2) Surgeon classifies patient on the basis of anaesthetic risk and nature and extent of proposed surgery as a high-risk patient, likely to require postoperative intensive care management. (3) Age 18 years or over. (4) No contraindications to insertion of an epidural catheter can be identified (e.g. intrathoracic, or major vascular (non-cerebral) surgery. It would be poor research strategy to delineate more admission criteria based upon specific details of disease severity for different organ systems (such as cardiac, respiratory, etc). First it might lead to exclusion of some very high-risk patients who ought to be studied. Second, it would place an additional, substantial burden of work on clinicians and investigators, without obvious benefit to the study. Furthermore, a simple approach to admission eligibility as recommended above is easily reproducible among investigators and enhances study comparability. 29 The major advantage in quantitating demographic and clinical variables preoperatively (such as age, weight, height, Goldman index of cardiac risk, spirometry, blood gases and serum biochemistry) is the value of this information in confirming true comparability between the control and experimental groupS. 33 It is known that age correlates with surgical mortality36,37 and that the Goldman index correlates with risk of postoperative cardiac complications. 38
3.2.2
General clinical conduct of the experimental manoeuvre and clinical anaesthesia.
(1) In patients allocated to receive epidural therapy and undergoing intrathoracic and upper abdominal surgery, a local anaesthetic block to the T 2 level should be achieved. For procedures involving pelvic surgery, a preoperative block down to the S4 dermatome must be achieved. A catheter must be securely placed in the epidural space to facilitate subsequent doses during and after surgery. (2) An equivalent level of intraoperative monitoring for both groups must be agreed to before the study and maintained through the surgery and the post-surgery period of study. This will prevent co-intervention. (3) During anaesthesia, intraoperative fluid therapy must optimise cardiac filling pressure according to the clinical procedure of the attending anaesthetist. Atropine should be used to maintain heart rate above 50 bpm.
Vasopressors should be used to maintain systolic pressure above 80 mmHg systolic or mean arterial pressure above 65 mmHg for previously normotensive patients and proportionately higher for previously hypertensive patients. (4) Postoperatively, adequate epidural pain relief must be maintained continuously for as long as clinically indicated: the use of local anaesthetics (LA) or opioids alone or LA/opioid combinations and the use of infusions and or intermittent bolus injection should be at the discretion of clinicians in charge. Vascular supportive therapy should be continued in the postoperative period, as indicated. Blood loss should be replaced by blood, as indicated. 39 The importance of avoiding contamination and co-intervention may require frequent reinforcement to clinicians caring for participating patients.
Outcome measures. Clinicians and nurses
caring for patients in the study should not be informed of outcome variables to be measured. This will minimise contamination and co-intervention. 15 Three types of measures should be considered: (1) Clinical outcome variables.
These should include mortality, and defined major morbidity variables. The variables defined in detail by Yeager, Glass et aI., were cardiovascular, respiratory, renal, gastrointestinal, pancreatic and hepatic failure, major infection (pneumonia and sepsis) and re-operation for a complication related to the original surgery (bleeding, infection, vascular occlusion). These represent the first attempt known to this author to comprehensively define, all of the important possible major complications in this group ofpatients. 29 They noted that standardised definitions do not exist and proposed definitions, prospectively based upon their own extensive clinical experience and the published experience of others, which suggested that outcome is worse whenever one of the events described occurred in the postoperative period. 29 Their definitions provide a useful model for a comprehensive set of outcome measures. Their use in future studies would help ensure comparability of results. (2) The metabolic response to trauma.
Several previous studies have shown that epidural block modifies or prevents endocrine responses to surgical trauma. 9 ,40-44 Accordingly, measurement of 24 hour urinary cortisol excretion is recommended as a means of independently validating in the experimental group, a therapy that modifies the stress response. 29 (3) Cost utilisation variables.
Most agencies concerned with health-care funding are concerned about increased hospital costs, particularly in intensive care units (ICU) where there is no doubt about the added expense of surgical morbidity.45 Accordingly, a major justification for the study proposed here is the prospect of reducing substantially the cost of surgical care. This should be a major factor for funding agencies in deciding the extent to which they would support such research. Accordingly, using cost utilisation variables that show a decline in surgical morbidity should enhance the possibility of support from funding agencies. 29 Possible variables which could be studied are: total anaesthesia time, duration of postoperative artificial ventilation, duration of postoperative endotracheal intubation, duration of postoperative ICU stay, duration of postoperative hospital stay, total in-hospital costs (bed, operating room, pharmacy, material services, etc), and total in-hospital medical charges (physician charges for anaesthesia, surgery, I CU, consultations, laboratories tests, X-rays, etc). The implementation of the research strategies outlined in this paper should help to provide more comparable data on the important question of the role of epidural block in improving outcome after surgery.
